Our patented ARO drug platform solves a critical dimension of the opioid crisis and will gain exclusive access to a >$12B addressable U.S. market in 2 ½ years.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free